Results 91 to 100 of about 36,802 (283)

Bleeding complications in \(\it bcr-abl\)-negative myeloproliferative neoplasms (MPN)

open access: yes, 2021
In patients with \(\it bcr-abl\)-negative myeloproliferative neoplasms (MPN), concerns are often raised about the use of anticoagulants because of an increased bleeding risk. However, there are few MPN studies focusing on bleeding.
Marchi, Hannah (M. Sc.)   +9 more
core   +1 more source

Myeloproliferative (MPN) Symptom Burden Response Thresholds: Assessment Of MPN-SAF TSS Quartiles As Potential Markers Of Symptom Response

open access: yes
Background We have previously reported on the significant, but heterogeneous baseline MPN symptom burden among an international sample of MPN patients (including essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (
Mesa, Ruben A.   +49 more
core   +1 more source

Schematic illustration for MPN-HBP1-mediated anticancer therapy.

open access: yes, 2023
The PEI-HBP1 coordinates with tannic acid and ferric ions to form MPN-HBP1. After MPN-HBP1 nanoparticles reach the tumor site via passive targeting, the tannic acid and ferric ions in the MPN coating enhance the Fenton reaction to induce ferroptosis in ...
Xiaowei Zhang (6505)   +9 more
core   +1 more source

Antimicrobial bilayer starch film containing zein electrospun fibers encapsulating thyme essential oil for cherry tomato packaging

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract Background This study evaluated the antimicrobial activity of thyme essential oil (TEO) encapsulated in electrospun zein fibers for use in bilayer films as active packaging for cherry tomatoes. The antimicrobial activity of TEO and bilayer films with 20%, 40%, and 60% TEO was assessed with agar diffusion and microatmosphere assays.
Jéssica Silveira Vitoria   +7 more
wiley   +1 more source

MPN himpun lebih 1,000 profesor [PDF]

open access: yes, 2011
KUALA LUMPUR - Majlis Profesor Negara (MPN) akan menghimpunkan lebih 1,000 profesor dari seluruh negara dalam Kongres Profesor Negara di Putra World Center (PWTC)di sini pada 6 dan 7 Julai ...
Sinar, Harian
core   +1 more source

Insomnia, Quality Of Life and MPN Symptom Burden: An Analysis By The MPN Quality Of Life International Study Group (MPN-QOL ISG)

open access: yes
Background We have previously reported on the high prevalence and severity of insomnia amongst a large international cohort of MPN patients (Emanuel JCO 2012).
Mesa, Ruben A.   +49 more
core   +1 more source

JAMM/MPN+-MPN− assembly.

open access: yes, 2014
(A,B,C) Ins-1 conformation and UBL binding. Residues discussed in the text are shown in stick mode and the zinc-coordinating residues in purple. Bottom panel: 90° rotated view with respect to the top panel. (A) AMSH-LP MPN Ins-1 bound to distal ubiquitin.
Melissa Birol (619685)   +10 more
core   +1 more source

JAK2 Variant and Parkinsonian Syndromes: Coincidence or Pathophysiological Link?

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background JAK2 variants are a hallmark of myeloproliferative neoplasms (MPNs), including polycythemia vera and essential thrombocythemia. These disorders are often associated with thrombotic and inflammatory complications. From a movement disorder perspective, chorea is a rare but well‐recognized neurological occurrence in this context ...
Elena Ardila Jurado   +5 more
wiley   +1 more source

Cluster analysis of inflammatory gene expression in MPN patients.

open access: yes, 2019
(A) Hierarchical clustering separates MF grade 0–1 MPN from MF grade 2–3 MPN in a training cohort of 76 patients. (B) K-means clustering (k = 4) separates prefibrotic (MF grade 0–1) disease from overtly fibrotic disease (MF grade 2–3). Four clusters with
Olga Pozdnyakova (3585275)   +6 more
core   +1 more source

Cannabis‐Based Oil for Pain and Other Non‐Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial

open access: yesMovement Disorders, EarlyView.
Abstract Background There is a lack of treatments for non‐motor symptoms (NMS) in Parkinson's disease (PD). Objective To assess the safety and effectiveness of an oral Cannabis sativa L. extract on pain and other NMS of PD. Methods This phase II, randomized, placebo‐controlled trial evaluated a formulation containing cannabidiol (CBD; 96 mg/ml) and Δ9 ...
Gabriel T. Kubota   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy